Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
35.75
+0.50 (1.42%)
Apr 30, 2026, 4:36 PM ICT

Mega Lifesciences PCL Ratios and Metrics

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
31,16929,20828,99035,09340,76044,029
Market Cap Growth
15.32%0.75%-17.39%-13.90%-7.43%41.26%
Enterprise Value
27,20926,05226,45232,88339,24242,440
Last Close Price
35.7532.7530.8635.9040.1641.84
PE Ratio
16.3015.2814.4117.6118.1822.62
Forward PE
13.3713.0711.2914.5217.7622.85
PS Ratio
2.202.061.882.232.593.11
PB Ratio
3.052.862.943.774.645.49
P/TBV Ratio
3.493.283.394.405.476.62
P/FCF Ratio
14.8013.8713.4621.2524.0917.10
P/OCF Ratio
11.2510.5412.0718.2220.4116.15
PEG Ratio
6.0843.5830.402.852.552.55
EV/Sales Ratio
1.921.841.722.092.503.00
EV/EBITDA Ratio
8.438.267.3210.4513.4517.84
EV/EBIT Ratio
9.228.837.7611.1914.4219.48
EV/FCF Ratio
12.9212.3712.2819.9123.1916.48
Debt / Equity Ratio
0.070.070.050.030.050.04
Debt / EBITDA Ratio
0.210.210.130.080.140.15
Debt / FCF Ratio
0.320.320.230.150.250.14
Net Debt / Equity Ratio
-0.39-0.39-0.34-0.27-0.27-0.27
Net Debt / EBITDA Ratio
-1.26-1.26-0.93-0.78-0.81-0.92
Net Debt / FCF Ratio
-1.88-1.88-1.56-1.49-1.41-0.85
Asset Turnover
0.950.951.091.091.131.14
Inventory Turnover
2.232.232.372.292.182.25
Quick Ratio
1.591.591.791.401.101.08
Current Ratio
2.232.232.612.261.911.92
Return on Equity (ROE)
19.03%19.03%20.99%22.04%26.66%25.87%
Return on Assets (ROA)
12.30%12.30%15.05%12.77%12.19%10.97%
Return on Invested Capital (ROIC)
36.71%36.76%43.75%39.14%38.39%30.35%
Return on Capital Employed (ROCE)
27.70%27.70%33.10%30.30%29.90%25.90%
Earnings Yield
6.13%6.55%6.94%5.68%5.50%4.42%
FCF Yield
6.76%7.21%7.43%4.71%4.15%5.85%
Dividend Yield
4.48%4.88%5.18%4.46%3.98%3.30%
Payout Ratio
72.96%72.96%69.30%72.23%62.71%47.41%
Total Shareholder Return
4.48%4.88%5.18%4.46%3.98%3.30%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.